Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 401 entries
View as:

Cardiac Autonomic Dysfunction in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05132673 Org: User:
Start: 01/31/25 End: 07/01/26 Due: 07/01/27

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT05468359 Org: User:
Start: 11/07/22 End: 06/30/37 Due: 06/30/38

Early Detection of Endotheliopathy Post-Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05594251 Org: User:
Start: 11/28/22 End: 05/05/24 Due: 05/05/25

Complementary Behavioral Interventions To Remediate Cognitive Impairment or Emotional Distress in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06989463 Org: User:
Start: 06/30/25 End: 06/30/26 Due: 06/30/27

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Phase: N/A Priority: Normal
NCT ID: NCT03755804 Org: User:
Start: 12/12/18 End: 07/01/28 Due: 07/01/29

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02259348 Org: User:
Start: 10/31/14 End: 03/31/16 Due: 03/31/17

Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon

Phase: N/A Priority: Normal
NCT ID: NCT01298206 Org: User:
Start: 10/31/11 End: 06/30/13 Due: 06/30/14

Next Generation Pathogen Sequencing for Prediction of Adverse Events

Phase: N/A Priority: Normal
NCT ID: NCT03226158 Org: User:
Start: 08/09/17 End: 05/01/25 Due: 05/01/26

Haploidentical HCT for Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04558736 Org: User:
Start: 01/21/21 End: 07/01/26 Due: 07/01/27

Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients

Phase: N/A Priority: Normal
NCT ID: NCT01383473 Org: User:
Start: 08/31/11 End: 07/31/12 Due: 07/31/13

Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT01071473 Org: User:
Start: 02/28/10 End: 10/31/12 Due: 10/31/13

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

Phase: N/A Priority: Normal
NCT ID: NCT01820117 Org: User:
Start: 04/26/13 End: 02/20/18 Due: 02/20/19

Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06646640 Org: User:
Start: 06/30/25 End: 01/31/50 Due: 01/31/51

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT05656248 Org: User:
Start: 01/17/23 End: 08/31/28 Due: 08/31/29

Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00664131 Org: User:
Start: 08/31/05 End: 10/31/08 Due: 10/31/09

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00760656 Org: User:
Start: 09/13/07 End: 12/31/25 Due: 12/31/26

Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection

Phase: N/A Priority: Normal
NCT ID: NCT01472965 Org: User:
Start: 12/29/11 End: 11/11/16 Due: 11/11/17

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

Phase: N/A Priority: Normal
NCT ID: NCT01205581 Org: User:
Start: 09/30/10 End: 08/31/13 Due: 08/31/14

Validation Study of Pediatric Patient-Reported Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03229837 Org: User:
Start: 08/01/17 End: 06/30/25 Due: 06/30/26

A Study of a Live Intranasal Influenza Vaccine in Children With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00906750 Org: User:
Start: 10/31/08 End: 07/31/11 Due: 07/31/12

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06579469 Org: User:
Start: 07/31/25 End: 03/31/29 Due: 03/31/30

Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01328496 Org: User:
Start: 06/15/11 End: 10/31/16 Due: 10/31/17

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Phase: N/A Priority: Normal
NCT ID: NCT05192889 Org: User:
Start: 08/25/22 End: 02/28/27 Due: 02/28/28

Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00674882 Org: User:
Start: 11/07/19 End: 10/03/22 Due: 10/03/23

Gene Editing For Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT06506461 Org: User:
Start: 03/21/25 End: 12/31/32 Due: 12/31/33